Abiopharma

Proposed issue of securities - MSB

Familiar Calderon Gerardo 🔴 sold 1.3K shares of Chemours Co (CC) at $15.40 Transaction Date: Sep 01, 2025 | Filing ID: 112928

Mesoblast Option to Issue up to US$50m Convertible Notes

New Form SCHEDULE 13D/A - vTv Therapeutics Inc. Filed: 2025-09-03 AccNo: 0001415889-25-023605 Size: 18 KB

Edgewise Therapeutics - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Director Cabral Timothy S 🟡 adjusted position in 0 shares (1 derivative) of VEEVA SYSTEMS INC (VEEV) Transaction Date: Sep 01, 2025 | Filing ID: 000005

Director Carges Mark T 🟡 adjusted position in 0 shares (1 derivative) of VEEVA SYSTEMS INC (VEEV) Transaction Date: Sep 01, 2025 | Filing ID: 000005

Director Hung Priscilla 🟡 adjusted position in 0 shares (1 derivative) of VEEVA SYSTEMS INC (VEEV) Transaction Date: Sep 01, 2025 | Filing ID: 000005

Director Hedley Mary Lynne 🟡 adjusted position in 0 shares (1 derivative) of VEEVA SYSTEMS INC (VEEV) Transaction Date: Sep 01, 2025 | Filing ID: 000003

Director MOHR MARSHALL 🟡 adjusted position in 0 shares (1 derivative) of VEEVA SYSTEMS INC (VEEV) Transaction Date: Sep 01, 2025 | Filing ID: 000004

Director SEKHRI PAUL J 🟡 adjusted position in 0 shares (1 derivative) of VEEVA SYSTEMS INC (VEEV) Transaction Date: Sep 01, 2025 | Filing ID: 000005

Nektar Therapeutics to Participate in Two Investor Conferences in September

New Form 4 for Spyre Therapeutics

Burrows Scott L 🔴 sold 18.4K shares of Spyre Therapeutics, Inc. (SYRE) at $16.26 Transaction Date: Sep 02, 2025 | Filing ID: 000095